• Return to Headlines

Downtrend Call Working As Intra-Cellular T Stock Falls 44.4% (ITCI)

By David Diaz

SmarTrend identified a Downtrend for Intra-Cellular T (NASDAQ:ITCI) on January 8th, 2020 at $27.19. In approximately 3 months, Intra-Cellular T has returned 44.43% as of today's recent price of $15.11.

In the past 52 weeks, Intra-Cellular T share prices have been bracketed by a low of $7.85 and a high of $44.92 and are now at $15.11, 92% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has declined 4.2%.

Intra-Cellular Therapies Inc. researches and develops biopharmaceutical drugs. The Company engages in the research and development of small molecule drugs to treat neuropsychiatric and neurological diseases and other disorders of the central nervous system. Intra-Cellular Therapies offers its products to the medical industry.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Intra-Cellular T.

Log in and add Intra-Cellular T (ITCI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights intra-cellular t

Ticker(s): ITCI